These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6818080)

  • 1. A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes.
    Taylor KG; John WG; Matthews KA; Wright AD
    Diabetologia; 1982 Dec; 23(6):507-10. PubMed ID: 6818080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes.
    Taylor KG; Wright AD; Carter TJ; Valente AJ; Betts SA; Matthews KA
    Diabetologia; 1981 May; 20(5):535-9. PubMed ID: 6793437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein and diabetes mellitus.
    Tanaka A; Uchimura I; Maezawa H
    Bull Tokyo Med Dent Univ; 1984 Jun; 31(2):85-91. PubMed ID: 6430582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.
    Lopes-Virella MF; Wohltmann HJ; Mayfield RK; Loadholt CB; Colwell JA
    Diabetes; 1983 Jan; 32(1):20-5. PubMed ID: 6336700
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.
    Schernthaner G; Kostner GM; Dieplinger H; Prager R; Mühlhauser I
    Atherosclerosis; 1983 Dec; 49(3):277-93. PubMed ID: 6229255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
    Dashti N; Ontko JA
    Atherosclerosis; 1983 Dec; 49(3):255-66. PubMed ID: 6419747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Dullaart RP; Dikkeschei LD; Doorenbos H
    Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.
    Joven J; Vilella E; Costa B; Turner PR; Richart C; Masana L
    Clin Chem; 1989 May; 35(5):813-6. PubMed ID: 2720975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
    Gumbiner B; Low CC; Reaven PD
    Diabetes Care; 1998 Jan; 21(1):9-15. PubMed ID: 9538963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM
    Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum high density lipoprotein in diabetic patients.
    Lopes-Virella MF; Stone PG; Colwell JA
    Diabetologia; 1977 Aug; 13(4):285-91. PubMed ID: 199515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein cholesterol and apolipoprotein a-1 concentrations in non-insulin dependent diabetics treated by diet and chlorpropamide.
    Billingham MS; Leatherdale BA; Hall RA; Bailey CJ
    Diabete Metab; 1982 Sep; 8(3):229-33. PubMed ID: 6814965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
    Oyelola OO; Ajayi AA; Babalola RO; Stein EA
    J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.
    Mazurkiewicz JC; Watts GF; Warburton FG; Slavin BM; Lowy C; Koukkou E
    J Clin Pathol; 1994 Aug; 47(8):728-31. PubMed ID: 7962626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased high density lipoproteins in diabetic children.
    Ewald U; Gustafson S; Tuvemo T; Vessby B
    Eur J Pediatr; 1984 Aug; 142(3):154-6. PubMed ID: 6432541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids and apolipoproteins in relation to glycaemic control and diabetic nephropathy in long-term survivors of diabetes: results of the Erfurt Study.
    Schauer UJ; Pissarek D; Lundershausen R; Rühling K; Winkler L; Panzram G
    Exp Clin Endocrinol; 1988 Mar; 92(3):280-6. PubMed ID: 3267003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.